LON:CTEC ConvaTec Group (CTEC) Share Price, News & Analysis GBX 256.20 -0.40 (-0.16%) As of 05/8/2025 12:15 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesBuy This Stock About ConvaTec Group Stock (LON:CTEC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get ConvaTec Group alerts:Sign Up Key Stats Today's Range 254.60▼ 25950-Day Range 231.20▼ 269.2052-Week Range 211.80▼ 271.20Volume5.38 million shsAverage Volume18.61 million shsMarket Capitalization£6.52 billionP/E Ratio43.15Dividend Yield1.95%Price TargetGBX 301.67Consensus RatingBuy Company OverviewConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.Read More… ConvaTec Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks36th Percentile Overall ScoreCTEC MarketRank™: ConvaTec Group scored higher than 36% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingBuy Consensus RatingConvaTec Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageConvaTec Group has only been the subject of 1 research reports in the past 90 days.Read more about ConvaTec Group's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of ConvaTec Group is 43.15, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.18.Price to Earnings Ratio vs. SectorThe P/E ratio of ConvaTec Group is 43.15, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.94.Price to Earnings Growth RatioConvaTec Group has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioConvaTec Group has a P/B Ratio of 3.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for CTEC. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldConvaTec Group pays a meaningful dividend of 1.27%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthConvaTec Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of ConvaTec Group is 84.20%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about ConvaTec Group's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for CTEC. News and Social Media0.6 / 5News SentimentN/A Search Interest2 people have searched for CTEC on MarketBeat in the last 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, ConvaTec Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought GBX 0 in company stock and sold £1,456,499.20 in company stock.Percentage Held by Insiders19.65% of the stock of ConvaTec Group is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions69.05% of the stock of ConvaTec Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about ConvaTec Group's insider trading history. Receive CTEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CTEC Stock News HeadlinesBarclays Remains a Buy on ConvaTec (CTEC)April 15, 2025 | markets.businessinsider.comConvaTec Group slides Monday, underperforms marketApril 7, 2025 | marketwatch.comSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.May 9, 2025 | Stansberry Research (Ad)UK Stocks That Might Be Trading Below Their Estimated Value In March 2025March 7, 2025 | finance.yahoo.comRBC Capital Keeps Their Buy Rating on ConvaTec (CTEC)March 6, 2025 | markets.businessinsider.comBarclays Keeps Their Buy Rating on ConvaTec (CTEC)March 6, 2025 | markets.businessinsider.comJefferies Keeps Their Buy Rating on ConvaTec (CTEC)February 27, 2025 | markets.businessinsider.comBarclays Sticks to Its Buy Rating for ConvaTec (CTEC)February 27, 2025 | markets.businessinsider.comSee More Headlines CTEC Stock Analysis - Frequently Asked Questions How have CTEC shares performed this year? ConvaTec Group's stock was trading at GBX 221.20 at the start of the year. Since then, CTEC shares have increased by 15.8% and is now trading at GBX 256.20. View the best growth stocks for 2025 here. How were ConvaTec Group's earnings last quarter? ConvaTec Group PLC (LON:CTEC) posted its quarterly earnings results on Friday, February, 28th. The company reported $12.00 earnings per share for the quarter, missing analysts' consensus estimates of $12.70 by $0.70. ConvaTec Group had a trailing twelve-month return on equity of 9.15% and a net margin of 6.96%. How do I buy shares of ConvaTec Group? Shares of CTEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of ConvaTec Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that ConvaTec Group investors own include EnQuest (ENQ), Centamin (CEY), Lloyds Banking Group (LLOY), Oxford Biomedica (OXB), Tullow Oil (TLW), Barclays (BARC) and Vodafone Group Public (VOD). Company Calendar Last Earnings2/28/2020Record date for 5/29 Dividend4/17/2025Ex-Dividend for 5/29 Dividend4/17/2025Today5/08/2025Dividend Payable5/29/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolLON:CTEC CIKN/A Webwww.convatecgroup.com Phone44 11 8952 8100FaxN/AEmployees10,000Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 301.67 High Stock Price TargetGBX 310 Low Stock Price TargetGBX 290 Potential Upside/Downside+17.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 5.94 Trailing P/E Ratio43.15 Forward P/E Ratio18.90 P/E Growth0.93Net Income£188.35 million Net Margins6.96% Pretax MarginN/A Return on Equity9.15% Return on Assets5.01% Debt Debt-to-Equity Ratio85.32 Current Ratio2.26 Quick Ratio0.96 Sales & Book Value Annual Sales£2.71 billion Price / Sales2.41 Cash FlowGBX 15.06 per share Price / Cash Flow17.01 Book ValueGBX 80.01 per share Price / Book3.20Miscellaneous Outstanding Shares2,543,000,740Free FloatN/AMarket Cap£6.52 billion OptionableNot Optionable Beta0.64 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (LON:CTEC) was last updated on 5/9/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ConvaTec Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share ConvaTec Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.